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The presence of fructose 2,6_bisphosphate (Fru 2,6-P,) in elicited peritoneal macrophages of rat was examined. These 
cells possess an active phosphofructokinase-2 which is diminished by citrate and only slightly inhibited by glycerol 3-phos- 
phate. Phosphofructokinase-1 submaximal activity was increased 26-fold by the addition of 1 PM Fru 2,6-P,. Incubation 
of cells without glucose decreased the amount of Fru 2,6-P, to zero, but further addition of 5 mM glucose increased 
the levels of the sugar ester 20-fold. In addition, the presence of phorbol ester potentiated the synthesis of Fru 2,6-P,. 
By contrast phenylisopropyladenosine or prostaglandin Fr. inhibited the production of Fru 2,6-P,. 
Fructose 2,6-bisphosphate; Lactate; Macrophage; (Peritoneal cell) 
1. INTRODUCTION 
Macrophages undergo a respiratory burst upon 
phagocytic stimulation or exposure to the soluble 
agonist phorbol ester or c&-polyunsaturated acids 
[l-4]. The biochemical sequence of this stimula- 
tion is likely to involve the activation of multiple 
pathways. One of these is the pentose phosphate 
shunt in order to provide NADPH for NADPH- 
oxidase [5]. Recently, it has been shown that 
elicited macrophages possess high levels of key en- 
zymes of the pentose phosphate shunt [6]. The ac- 
tivity of glucose 6-phosphate dehydrogenase in 
mouse macrophages is almost 8-fold higher than 
that found in mouse liver, and these cells also 
possess high activities of 6-phosphogluconate 
dehydrogenase, hexokinase and 6-phosphofructo- 
kinase. It has been suggested that the glycolytic 
pathway is enhanced during phagocytosis [7]. 
The present study investigates whether fructose 
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2,6-bisphopshate (Fru 2,6-Pz), a potent stimulator 
of phosphofructokinase-1 in many cells [8,9], is 
present in macrophage cells, and, in addition, 
whether it plays a role in regulating the glycolytic 
flux when these cells are incubated with different 
types of stimulators. In this work it is shown that 
Fru 2,6-P2 is present in macrophages and other 
peritoneal cells at similar levels to those found in 
liver and that its concentration is modified during 
cell activation. 
2. MATERIALS AND METHODS 
Elicited macrophages were obtained from the peritoneal cavi- 
ty of male Wistar rats 3 days after injection of 5 ml of 6% ca- 
sein in 0.9% NaCl as in [lo]. The cells were washed in Krebs 
Ringer bicarbonate (KRB) [ll] buffered with 10 mM Hepes, 
pH 7.4, and oxygenated with Oz/COz (95:5). The cells were 
maintained in an incubator at 37°C in air/CO2 (19: 1) in fresh 
KRB-Hepes supplemented with 2% (w/v) bovine serum 
albumin and 10 mM glucose. After 2 h of incubation the cell- 
culture dishes were washed three times with cold KRB-Hepes to 
remove non-adherent cells. In some experiments these super- 
natants were centrifuged and the pellet of cells suspended in 
fresh buffer KRB-Hepes. The adherent macrophages were gent- 
ly separated with a rubber policeman and suspended in KRB- 
Hepes without additions unless otherwise indicated. The sum of 
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adherent plus non-adherent cells is referred to in the text as total 
peritoneal cells. This preparation of macrophages was in- 
cubated in KRB-Hepes without additions for 1 h’(preincubated 
cells) in order to deplete intracellular glycogen and to obtain 
low levels of Fru 2,6-Pz and lactate. The cells were then in- 
cubated with the additions indicated in the text. Fru 2,6-P* was 
extracted and measured as in [12]. Medium lactate was assayed 
as in [13] and glycogen as in [14]. Phosphofructokinase-1 [15] 
and phosphofructokinase-2 [16] activities were analyzed in 
preparations partially purified with polyethylene glycol by the 
standard methods. The level of protein was analyzed by a 
modified Lowry method [17]. Fru 2,6-Pz standard was kindly 
donated by E.V. Schaftingen and H.G. Hers (Laboratoire de 
Chimie Physiologique, Brussels, Belgium). All biochemical and 
purified enzymes were obtained from Sigma and Boehringer. 
3. RESULTS AND DISCUSSION 
3.1. Characterization of fructose 
2,&bisphosphate nzymatic system 
Fig.1 shows the time course of intracellular 
levels of Fru 2,6-PZ and the concentration of lac- 
tate in the medium in elicited total peritoneal cells 
incubated without additions. For the untreated 
cells the total amount of Fru 2,6-P2 was about 
70 pmol/mg protein, which represents a value 
similar to that found in many cells (review [ 18)). 
Over 30-60 min of incubation this value declined 
to practically zero. At this time, an increase in the 
concentration of lactate released to medium was 
observed. The analysis of the glycogen levels in 
these conditions reveals that in non-incubated cells 
there was 22.1 pg/mg protein, and this value 
decreased to 2.5 pg/mg protein after 90 min. This 
indicates that the high levels of Fru 2,6-PZ ob- 
served at the beginning of incubation time (and 
presumably of other glycolytic intermediates) was 
sustained by the degradation of glycogen. By con- 
trast, in preincubated cells (e.g. with low levels of 
glycogen) the concentration of Fru 2,6-P2 was also 
low. A correlation between both parameters (Fru 
2,6-P2 and glycogen) was described in the adipose 
tissue [ 191. The analysis of partially purified 
PFK-1 /PFK-2 system in untreated macrophages 
gave the following results: (i) the incubation of 
PFK-2 with 1.6 pg/O.2 ml catalytic subunit of 
CAMP-dependent protein kinase and 0.5 mM 
MgATP did not modify its activity at either pH 6.6 
(active form) or pH 8.5 (total activity) [16] (not 
shown); (ii) PFK-2 activity was inhibited about 
73% by 0.5 mM citrate, while a lack of effect was 
observed with glycerol 3-P. These properties 
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Fig.1. Levels of Fru 2,6-Pz (0) and lactate (0) in total 
peritoneal cells incubated without additions. Values shown are 
the means of two separate xperiments. 
resemble those of the cardiac isoenzyme of PFK-2 
[20]; and (iii) the activity of PFK-1 assayed under 
submaximal conditions (2.5 mM ATP and 0.1 mM 
Fru 6-P at pH 7.0) was stimulated about 26-fold 
after the addition of 1 PM Fru 2,6-P2. 
The effect of medium glucose concentration on 
Fru 2,6-P2 concentration in preincubated or non- 
preincubated macrophages was studied in the next 
experiments. Maximal values were found at 5 mM 
glucose. Higher levels of the sugar did not increase 
the concentration of Fru 2,6-P2. The apparent &.s 
for glucose was about 0.5 mM in preincubated 
cells. Under this condition, it is noteworthy that 
5 mM glucose produced a 20-fold increase in the 
concentration of Fru 2,6-P2 as compared to con- 
trol cells. It was also observed that in non- 
preincubated macrophages the initial amount of 
Fru 2,6-P2 was higher than in 1 h preincubated 
cells. However, at 5 mM glucose maximal values 
of Fru 2,6-P2 were similar in both conditions. The 
release of lactate followed a profile like that of Fru 
2,6-P2 synthesis (not shown). 
3.2. Effect of phorbol ester 
Fig.2 shows the effect of PMA on Fru 2,6-P2 
levels in purified macrophages incubated at dif- 
ferent concentrations of glucose. PMA enhanced 
the effect of glucose to increase the Fru 2,6-P2 con- 
Volume 25 1, number 1,2 FEBS LETTERS July 1989 
2 P 
k0 b. ,I 
0 1 2 3 4 5 
[Glucose 1 (m M 1 
Fig.2. Effect of PMA on Fru 2,6-P2 concentration in 
macrophages incubated with various concentrations of glucose. 
Previously the cells were preincubated without additions. The 
concentration of Fru 2,6-PZ was measured in cells incubated for 
1 h with (0) or without (0) 100 nM PMA. Values shown are 
the means + SE for four separate xperiments. 
centration. At 5 mM glucose, which produces a 
maximal amount of Fru 2,6-P2, the stimulation by 
PMA reached about 50% over the control cells. By 
contrast to this effect, the addition of PMA to 
macrophages was not followed by an increase in 
the release of lactate and this fact was independent 
of whether the cells were preincubated or not. 
Although it is not possible to give a definitive ex- 
planation about this fact, it could be suggested that 
the occurrence of recycling of glycolytic in- 
termediates after the phosphofructokinase-1 step. 
Moreover, this seems to be particularly the case in 
macrophages, since in other peritoneal cells, non- 
macrophages, PMA affected both parameters (e.g. 
Fru 2,6-P2 and lactate levels) (not shown). 
3.3. Effect of other agonists 
The following experiments were addressed to 
analyze in purified macrophages the effect of 
several agents known to alter some specific func- 
tions of phagocyting cells [21]. The cells were 
preincubated without additions and further in- 
cubated in the presence of 10 mM glucose and the 
indicated agonists for 1 h. Under some of these 
conditions, as e.g. after phenylisopropyladenosine 
or prostaglandin FZLY, the concentrations of Fru 
2,6-P2 are significantly reduced (table 1). These lat- 
ter agents cause an increase in intracellular cyclic- 
Table 1 
Fructose 2,6-bisphosphate concentration of maWphases 
incubated with various agonists 
Additions Fru 2,6-Ps 
(pmol/mg protein) 
Control 28.25 f 1.1 
PIA (50 ,uM) 21.38 k 0.8” 
PGF;?, (50 ,uM) 17.73 f 0.98 
ADP/ATP (SO/l00 cM) 27.99 f 1.2 
Peroxidase (50 U/ml) 27.83 f 1.0 
NaI04 (0.; nM) 26.72 f 1.3 
Purified macrophages were incubated without additions for 
1 h. The cells were washed and further incubated with 10 mM 
glucose and the following additions for 1 h: PIA, 
phenylisopropyladenosine; prostaglandin FZG ADPIATP; 
peroxidase and Na periodate. Values shown are means + SE for 
three separate xperiments. * P < 0.01 vs control 
AMP levels in neutrophils [22] and in monocytes 
[23]. However, this does not explain the decrease 
of Fru 2,6-P2 due to the lack of inhibition by 
phosphorylation (cyclic-AMP dependent) of 
PFK-2 from macrophages. By contrast the 
presence of ADP/ATP, peroxidase and NaI04 did 
not modify the levels of Fru 2,6-P2. The same 
result was found with insulin (not shown). On the 
other hand, the addition of digitonin (10 pg/ml) 
which enhances the production of anion superox- 
ide [24] killed, the cells after 1 h of incubation, and 
therefore rendered the measurement of Fru 2,6-P2 
inappropriate. 
4. CONCLUSIONS 
Fructose 2,6-bisphosphate is a potent activator 
of phosphofructokinase-1 obtained from a variety 
of tissues. In normal conditions, the role of Fru 
2,6-Pz in controlling the rates of glycolysis and 
gluconeogenesis is well accepted, although some 
doubts arose when the glycolysis was stimulated by 
anoxia in isolated hepatocytes [25]. The present 
results demonstrate that Fru 2,6-Pz is present in 
non-stimulated macrophages, and that the levels of 
Fru 2,6-P2 can be increased about 20-fold over 
control by glucose. Our data also show that the 
concentrations of Fru 2,6-P2 are modulated by fac- 
tors such as PMA, phenylisopropyladenosine, 
prostaglandin Fz~ or by the removal of glucose 
from external medium. In order to analyze 
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whether Fru 2,6-PZ levels may be taken as an index 
of glycolytic flux in macrophages, the relationship 
between its values and the amount of released lac- 
tate, obtained in the same experiment, was 
calculated. There is an acceptable correlation index 
(r = 0.883) between both parameters. This suggests 
that Fru 2,6-P2 regulates the glycolytic flux in the 
cells by the activation of PFK-1, which is consis- 
tent with the observation that Fru 2,6-P2 increased 
the activity in a purified preparation of PFK-1 
from macrophages. 
The positive effect of glucose and PMA was also 
evident in peritoneal cells other than macrophages. 
The amount of macrophages represent approx. 
90% of the total number of peritoneal cells. The 
other peritoneal cells are mainly composed of lym- 
phocytes and polymorphonuclear leukocytes [26]. 
The occurrence of Fru 2,6-P2 in lymphocytes B was 
previously demonstrated, and also its modulation 
by PMA [16]. 
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